Kevin Parker retweeted
LY6G6D is the next DLL3
We had a productive day in Houston at the 39th Annual Meeting of #SITC24 last week, engaging with industry experts and presenting #preclinical data on LY6G6D. We appreciate everyone who visited our poster to learn more about our efforts toward advancing CB21 for MSS CRC patients.
Kevin Parker retweeted
Cartography Biosciences is putting its name on the map, exiting stealth mode with $57 million for its antigen atlas fiercebiotech.com/biotech/ca…
Excited to participate in @CartographyBio’s $57M launch today alongside @a16z & @8vc and partner with @Satpathology, @krparker and @HowardYChang! Cartography is leveraging its precision cancer atlas to advance immunotherapies.
endpts.com/in-bid-to-avoid-i…
Proud to be working with you @ArtisVentures @vasudevbailey
Glad to be working with you @JorgeCondeBio @beckypferdehirt and the amazing @a16z bio team @vintweeta @vijaypande @julesyoo @JayRughani @GingerLiau @kkerames
Cancer immunotherapies are only as good as their targets — they must kill cancer cells while sparing healthy ones. 🎯
By bridging the worlds of biology + computation, @CartographyBio is building a comprehensive atlas to navigate this tricky terrain. 🗺
a16z.com/2022/07/19/investin…
Excited to announce @CartographyBio's launch to bring precision immunotherapies to patients - precise therapies start with precise antigens
We’re excited to officially launch Cartography Biosciences today with $57M in initial financing. With this support, we will create a smarter roadmap for #cancer immunotherapies with our precision antigen expression atlas. 🧵
#Oncology #MedTwitter
businesswire.com/news/home/2…
Glad to be working with an amazing founding team @Satpathology @HowardYChang @JeffreyVerboon @MaxMumbach @CalebLareau that has grown to an incredible group at Cartography
and couldn't ask for a better set of partners at @8vc @a16z @Wing_VC @CatalioCapital @ArtisVentures @AMECloudVC @CancerResearch @GaingelsVC








